CVS (CVS) disappointed Wall Street Wednesday by missing revenue estimates and revising down its 2024 guidance and expects to raise insurance plan prices in the coming year as it adjusts for Medicare ...

Diversified healthcare company CVS Health (NYSE:CVS) reported in Q3 CY2025, with sales up 7.8% year on year to $102.9 billion. Its non-GAAP profit of $1.60 per share was 17.9% above analysts’ ...

CVS has emerged as an outlier during the ongoing implosion observed in the healthcare insurance sector, as they drive improved YoY margins despite the rising medical costs. This is on top of the ...